Cecilia Guzmán
About
In The Last Decade
Cecilia Guzmán
9 papers receiving 396 citations
Peers
Comparison fields: 5 of 69
- Oncology 175
- Pulmonary and Respiratory Medicine 161
- Cancer Research 149
- Molecular Biology 100
- Biotechnology 60
Countries citing papers authored by Cecilia Guzmán
This map shows the geographic impact of Cecilia Guzmán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Guzmán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Guzmán more than expected).
Fields of papers citing papers by Cecilia Guzmán
This network shows the impact of papers produced by Cecilia Guzmán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Guzmán. The network helps show where Cecilia Guzmán may publish in the future.
Co-authorship network of co-authors of Cecilia Guzmán
This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Guzmán. A scholar is included among the top collaborators of Cecilia Guzmán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Guzmán. Cecilia Guzmán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Financial swot of Ecuadorian private banks after fall in petroleum prices, 2015-2016 | 14 |
| 2 | 50 | |
| 3 | 32 | |
| 4 | 77 | |
| 5 | 70 | |
| 6 | 55 | |
| 7 | 38 | |
| 8 | A phase I and pharmacokinetic study of ecteinascidin-743 on a daily x 5 schedule in patients with solid malignancies. | 75 |
| 9 | Pr e o p e r a t i ve CA 15.3 and prognosis in primary breast cancer | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.